TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
SRRK

Scholar Rock Holding Corp

Healthcare · Biotechnology

49.00$ -0.7% vs. previous close Closing price · As of: Sep 17, 2026

Ownership

Ownership Structure

Who owns Scholar Rock Holding Corp (SRRK)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 85.5% of the shares are freely tradable; institutional investors hold 116.6%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 116.6%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 0.8%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 85.5%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 18.5%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 122Mio.

Largest Shareholders

Institutions

Institutions SRRK
Name Stake (%) Shares Change (%) Date
FMR Inc 14.16 17,243,152 +12.1 03/31/2026
Siren, L.L.C. 8.89 10,825,013 +0.0 03/31/2026
BlackRock Inc 6.13 7,469,293 +3.5 03/31/2026
Samsara BioCapital, LLC 5.66 6,897,652 +0.0 06/30/2026
Wellington Management Company LLP 5.52 6,727,085 +0.1 06/30/2026
T. Rowe Price Associates, Inc. 5.10 6,206,618 -3.1 03/31/2026
Redmile Group, LLC 3.54 4,311,092 -52.5 06/30/2026
Orbis Allan Gray Ltd 3.43 4,179,983 +21.9 03/31/2026

Funds

Funds SRRK
Name Stake (%) Shares Change (%) Date
Fidelity Growth Compy Commingled Pl S 4.96 6,037,122 +0.0 07/31/2026
Fidelity Growth Company Fund 3.70 4,510,671 +0.0 07/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?